Timing and evolution of advanced conduction disturbances in patients with right bundle branch block undergoing transcatheter aortic valve replacement.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 04 02 2020
revised: 25 03 2020
accepted: 13 05 2020
pubmed: 2 9 2020
medline: 24 6 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

This study sought to determine the timing and evolution over time of advanced conduction disturbances (CDs) in patients with baseline right bundle branch block (RBBB) undergoing transcatheter aortic valve replacement (TAVR). One hundred and ten consecutive patients with pre-existing RBBB were included (out of 1341, 8.2%). All arrhythmias during the hospitalization period were recorded. Follow-up was performed at 30 days, 1 year, and yearly thereafter. Conduction recovery and ventricular pacing percentage (VPP) was evaluated at 30 days in those patients with permanent pacemaker implantation (PPMI). Sixty-one (55.5%) patients suffered advanced CDs [97% complete or high-degree atrioventricular block (CHB/HAVB)], and the vast majority (98%) occurred within the first 3 days post-procedure (intraprocedural: 85%). Fifty-two (47.3%) patients had PPMI (vs. 11.0% in non-RBBB patients, P < 0.001). Ventricular pacing percentage at 1 month was higher in patients with persistent-intraprocedural CHB/HAVB compared to those with transient-intraprocedural or post-procedural CHB/HAVB [99 (interquartile range, IQR 97-100)% vs. 72 (IQR 30-99)%, P = 0.02]. Complete recovery (VPP < 1%) was observed in only one patient (2%) with CHB/HAVB. After hospital discharge, no symptomatic bradyarrhythmias or sudden death occurred within 30 days. Patients with pre-existing RBBB exhibited a higher risk of PPMI at 4-year follow-up (26% vs. 8% in non-RBBB patients, P < 0.001). In patients with pre-existing RBBB, the vast majority of advanced CDs occurred within the 3 days following TAVR, and most did not recover at 1-month, particularly those with intra-procedural persistent CHB/HAVB. These results should help to determine the hospitalization length and timing of PPMI in RBBB patients undergoing TAVR.

Identifiants

pubmed: 32869083
pii: 5899883
doi: 10.1093/europace/euaa149
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1537-1546

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Guillem Muntané-Carol (G)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

David Del Val (D)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

Lucía Junquera (L)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

Laurent Faroux (L)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

Robert Delarochellière (R)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

Jean-Michel Paradis (JM)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

Siamak Mohammadi (S)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

Dimitri Kalavrouziotis (D)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

Eric Dumont (E)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

François Philippon (F)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

Josep Rodés-Cabau (J)

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH